"name","id","description","label","instanceType","uuid:ID","text"
"OBJ1","Objective_1","Main objective","","Objective","d0de29c6-8253-4311-8739-21621bdd223e","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg])."
"OBJ2","Objective_2","Safety","","Objective","876057eb-ce05-4399-b43a-876677266fc6","To document the safety profile of the xanomeline TTS."
"OBJ3","Objective_3","Behaviour","","Objective","950a79bf-e4dc-4863-811c-d918bfcb3163","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas."
